source
- Garner Health secures $100 million funding, valuation climbs to $2.7 billionGarner Health announced a $100 million financing round that pushes its post‑money valuation to $2.7 billion. The capital raise was completed last month and was led by a group of venture investors.…
- GSK to acquire Nuvalent for $10.6 billion, expanding its lung-cancer pipelineGSK announced it will buy Cambridge-based biotech Nuvalent for $10.6 billion, paying $124 per share, a 26% premium to the biotech's recent average share price. Nuvalent has two lung‑cancer drugs u…